EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

In vitro and in vivo studies of a newly synthesized copper-cetyl tri-methyl ammonium bromide combined with gallium oxide nanoparticles complex as an antitumor agent against hepatocellular carcinoma

Fatma Sm Moawed, Riham Abdel-Hamid Haroun iD, Eman S Abou Zaid, Somya Z Mansour, Abdel-Fattah M Badawi, Eman I Kandil

International Journal of Immunopathology and Pharmacology · 2023

DOI: 10.1177/03946320231180708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Immunopathology and Pharmacology, 2023. Verfasst von Fatma Sm Moawed und 5 weiteren Autor:innen. Beteiligte Einrichtung: Health Radiation Research Department, National Centre for Radiation Research and Technology, Atomic Energy Authority, Cairo, Egypt. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antineoplastic Agents, Gallium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Hepatocellular carcinoma (HCC) is one of the most leading causes of death worldwide. Previous studies reported that gallium alone and cetyltrimethylammonium bromide (CTAB) have antineoplastic activities; therefore, this study aimed to evaluate the activity of copper‐cetyl tri‐methyl ammonium bromide with gallium oxide nanoparticles (Cu‐CTAB+GaO‐NPs) against HCC by using in vitro and in vivo studies.

Methods

In vitro study was performed to evaluate the cytotoxic effects of Cu‐CTAB+GaO‐NPs and GaO‐NPs on HepG‐2 cell line using crystal violet dye assay. In vivo study was done on diethyl nitrosamine (DEN) induced HCC Wister rats. Rats were randomly divided into eight groups; control, Cu‐CTAB, GaO‐NPs, Cu‐CTAB+GaONPs, DEN, DEN+Cu‐CTAB, DEN+GaO‐NPs and DEN+Cu‐CTAB+GaO‐NPs. Histopathological examination of liver and biochemical parameters such as liver function markers, oxidative stress-antioxidants markers, tumor makers, apoptosis makers were studied.

Results

Results obtained from in vitro study revealed that Cu‐CTAB+GaO‐NPs and GaO‐NPs affect the cell viability of HepG‐2 cancer cell with IC50 0.2 μg/ml and 360 μg/ml, respectively. Cu‐CTAB+GaO‐NPs exerted an antiproliferative effect in experimental rat models of HCC, as demonstrated both histologically, since it facilitated the tissue recovery of the damaged liver, and biochemically as showed by the reduction of liver function markers (ALT & AST), oxidative stress markers (MDA) and tumor makers (AFP,TGF‐β1,α‐L–Fucosidase); while antioxidants markers (SOD), apoptosis markers (caspase‐3 mRNA) and araginase activity were elevated in DEN+Cu‐CTAB, DEN+GaO‐NPs and DEN+Cu‐CTAB+GaO‐NPs groups when compared to DEN group.

Conclusion

The present study demonstrated that both Cu‐CTAB alone and/or combined with GaO‐NPs exerted cytotoxic effects against DEN-induced HCC, which would in turn, speculate a possible therapeutic role of the novel Cu‐CTAB+GaO‐NPs compound.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAntineoplastic AgentsGalliumNanoparticlesRatsAnimalsCopperAntioxidantsCetrimoniumRats, WistarQuaternary Ammonium CompoundsBromides

Stichwörter der Autor:innen

Cetrimonium bromideDiethyl nitrosamineGallium oxide nanoparticlesHepatocellular carcinomaNanomedicineNanoparticles

Substanzen

CopperAntioxidantsCetrimoniumAntineoplastic AgentsGalliumammonium bromideQuaternary Ammonium CompoundsBromidesgallium oxide

Autor:innen und Institutionen

  • Health Radiation Research Department, National Centre for Radiation Research and Technology, Atomic Energy Authority, Cairo, Egypt.
  • Biochemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt.
  • Radiation Biology Department, National Centre for Radiation Research and Technology, Atomic Energy Authority, Cairo, Egypt.
  • Petrochemical Department, Egyptian Petroleum Research Institute, Cairo, Egypt.

ORCID-Profile: Riham Abdel-Hamid Haroun

Zitieren

APA

Moawed, F. S., Haroun, R. A., Abou Zaid, E. S., Mansour, S. Z., Badawi, A. M., & Kandil, E. I. (2023). In vitro and in vivo studies of a newly synthesized copper-cetyl tri-methyl ammonium bromide combined with gallium oxide nanoparticles complex as an antitumor agent against hepatocellular carcinoma. International Journal of Immunopathology and Pharmacology. https://doi.org/10.1177/03946320231180708

Vancouver

Moawed FS, Haroun RA, Abou Zaid ES, Mansour SZ, Badawi AM, Kandil EI. In vitro and in vivo studies of a newly synthesized copper-cetyl tri-methyl ammonium bromide combined with gallium oxide nanoparticles complex as an antitumor agent against hepatocellular carcinoma. International Journal of Immunopathology and Pharmacology. 2023. doi:10.1177/03946320231180708

BibTeX
@article{Moawed2023,
  author = {Moawed, Fatma Sm and Haroun, Riham Abdel-Hamid and Abou Zaid, Eman S and Mansour, Somya Z and Badawi, Abdel-Fattah M and Kandil, Eman I},
  title = {In vitro and in vivo studies of a newly synthesized copper-cetyl tri-methyl ammonium bromide combined with gallium oxide nanoparticles complex as an antitumor agent against hepatocellular carcinoma},
  journal = {International Journal of Immunopathology and Pharmacology},
  year = {2023},
  doi = {10.1177/03946320231180708}
}
Kostenlos starten →